Simultaneously, elevated STEAP2 levels are observed in hepatocellular carcinoma, where STEAP2 facilitates HCC cell motility and invasion by enhancing copper levels and activating certain proteins (Torrez et al., 2024). Here, STEAP2 is linked to hepatocellular carcinoma.